Joint Statement on Proposals for the FY2025 Off-year Drug Price Revision and National Biopharmaceutical Strategy
November 15, 2024
Japan Pharmaceutical Manufacturers Association (JPMA)
Pharmaceutical Research and Manufacturers of America (PhRMA)
European Federation of Pharmaceutical Industries and Associations (EFPIA Japan)